NAC also grants stock options to Directors and Employees
OTTAWA, May 7, 2018 /CNW/ - National Access Cannabis Corp. ("NAC" or the "Company") (TSXV: NAC), Canada's best practices leader in delivering secure, safe, and responsible access to legal cannabis today announced that Felipe Campusano has joined the Company's Board of Directors. The Company also announces the resignation of Jeff Hunt from the Board of Directors.
"Although we are actively building a dominant recreational retail foot print across Western Canada, NAC has not lost sight of the importance of our medical clinic practice to Canadians exploring the benefit of prescription cannabis," said Mark Goliger, Chief Executive Officer of National Access Cannabis. "We're very fortunate to have Felipe join our Board, bringing important insight and experience in successfully operating Canadian pharmacies. With his valuable insight and guidance, we will look to expand our initial network of 40 pharmacies to hundreds more across Canada. Developing a strong pharmacy program will provide NAC with strong credibility and brand recognition and opportunities to license the business system in international markets, like Germany."
Mr. Goliger added: "I, along with the board members and management of the Company, thank Jeff for his guidance and dedication to NAC and his ongoing commitment to remain a brand ambassador after his departure."
Felipe Campusano graduated from The University of Toronto Faculty of Pharmacy in 2006. Concurrent with the day he received his license, Campusano purchased his first pharmacy in a remote location of Northern Ontario. Over the course of the last 12 years Felipe had accumulated interest in over 50 pharmacies across Canada. He is one of the founding Partners and current President of Liver Care Canada a company that facilitates treatments of all liver diseases.
The Company also announces that on May 7, 2018 the board of directors of the Company granted an aggregate of 600,000 stock options (the "Options") to purchase common shares of the Corporation ("Shares") to certain directors, officers, employees and consultants of the Corporation. The Options vest on a monthly basis for 12 months and are exercisable for a period of five years from the date of grant at an exercise price of $0.86 per Share. Each grant of Options is subject to the approval of the TSX Venture Exchange.
About National Access Cannabis
National Access Cannabis is Canada's best practices leader in delivering secure, safe, and responsible access to legal cannabis. Through its Canada-wide network of care centres and retail locations, NAC enables patients and the public to gain knowledge and access to Canada's disparate network of authorized Licensed Producers of Cannabis. NAC improves the quality of life of its local clients and provides services designed to inform, educate and supply expert advice.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE National Access Cannabis Corp.
For further information: National Access Cannabis Corp., Mark Goliger, Chief Executive Officer, 1 (800) 411-1126, [email protected]; Investor Relations, Robert Kelly, LodeRock Advisors Inc., (416) 992-4539, [email protected]